NASDAQ
Pacira BioSciences, Inc. (PCRX) has a price/sales ratio of 1.59x as of Friday, May 22, 2026. This represents a 42.82% decrease compared to its 12-month average of 2.78x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.